Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan 9;299(2):194-201.
doi: 10.1001/jama.2007.55-a.

Variation of breast cancer risk among BRCA1/2 carriers

Colin B Begg  1 , Robert W Haile, Ake Borg, Kathleen E Malone, Patrick Concannon, Duncan C Thomas, Bryan Langholz, Leslie Bernstein, Jørgen H Olsen, Charles F Lynch, Hoda Anton-Culver, Marinela Capanu, Xiaolin Liang, Amanda J Hummer, Cami Sima, Jonine L Bernstein
Affiliations

Variation of breast cancer risk among BRCA1/2 carriers

Colin B Begg et al. JAMA. .

Abstract

Context: The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers.

Objectives: To determine the extent to which risks for BRCA1 and BRCA2 carriers vary with respect to observable and unobservable characteristics.

Design, setting, and participants: Probands were identified from a population-based, case-control study (Women's Environmental Cancer and Radiation Epidemiology [WECARE]) of asynchronous contralateral breast cancer conducted during the period of January 2000 to July 2004. Participants previously diagnosed with contralateral breast cancer or unilateral breast cancer were genotyped for mutations in BRCA1 and BRCA2. All participants had their initial breast cancer diagnosed during the period of January 1985 to December 2000, before the age of 55 years.

Main outcome measure: Incidence of breast cancer in first-degree female relatives of the probands was examined and compared on the basis of proband characteristics and on the basis of variation between families.

Results: Among the 1394 participants with unilateral breast cancer, 73 (5.2%) were identified as carriers of deleterious mutations (42 with BRCA1 and 31 with BRCA2). Among the 704 participants with contralateral breast cancer, 108 (15.3%) were identified as carriers of deleterious mutations (67 with BRCA1 and 41 with BRCA2). Among relatives of carriers, risk was significantly associated with younger age at diagnosis in the proband (P = .04), and there was a trend toward higher risk for relatives of contralateral breast cancer vs unilateral breast cancer participants (odds ratio, 1.4 [95% confidence interval, 0.8-2.4]; P = .28). In addition, there were significant differences in risk between carrier families after adjusting for these observed characteristics.

Conclusion: There exists broad variation in breast cancer risk among carriers of BRCA1 and BRCA2 mutations.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cumulative Breast Cancer Incidence in Relatives of Probands
The graphs show the estimated cumulative risks of breast cancer in first degree female relatives of different categories of proband. The benchmark is the cumulative risk of breast cancer reported by the SEER registries (see text). Pink - SEER 1990-1994; Blue - Cumulative risks in relatives of non-carrier UBC probands; Orange - Cumulative risks in relatives of non-carrier CBC probands; Green - Cumulative risks in relatives of BRCA1/2 carrier UBC probands; Yellow - Cumulative risks in relatives of BRCA1/2 carrier CBC probands.
See this image and copyright information in PMC

References

    1. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401–8. - PubMed
    1. Anglian Breast Cancer Study Group Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer. 2000;83:1301–8. - PMC - PubMed
    1. Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF. Risk models for familial ovarian and breast cancer. Genet Epidemiol. 2000;18:173–90. - PubMed
    1. Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev. 1999;8:741–7. - PubMed
    1. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700–10. - PMC - PubMed

Publication types